Table 3.
Author | Early Outcomes | Technical Success | Mortality | Stroke | Spinal Cord Ischemia | Re-Interventions | Acute Kidney Injury |
---|---|---|---|---|---|---|---|
Redlinger et al. [14] | 30-day | 100% | 1 | 0 | 1 | NA | 0 |
Liu et al. [15] | 30-day | 100% | 0 | 1 | NA | 1 | NA |
Sonesson et al. [16] | 30-day | 90% | 0 | 1 | NA | NA | NA |
Yan et al. [17] | 30-day | 100% | 2 | 1 | NA | NA | NA |
Li et al. [18] | 30-day | 97.8% | 3 | 5 | 0 | NA | NA |
Evans et al. [19] | 30-day | 100% | 2 | 3 | 2 | NA | 4 |
Footnotes: NA: non-applicable.